Boosting the immune response against canine osteosarcoma using specialized immune cells
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation
This study is looking at ways to boost the immune system in dogs with osteosarcoma by using special treatments that help important immune cells work better, with the hope that what they learn can also help improve cancer treatments for people.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts University Boston NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11255126 on NIH RePORTER |
What this research studies
This research investigates how to enhance the immune response in dogs with osteosarcoma by hyperactivating dendritic cells, which are crucial for initiating T cell responses. The approach involves using a combination of tumor lysate and specific immune-stimulating agents to promote the migration and function of these cells. By studying this process in dogs, the researchers aim to create a model that closely resembles human cancers, potentially leading to better treatments for both species.
Who could benefit from this research
Good fit: Ideal candidates for this research are dogs diagnosed with osteosarcoma who are eligible for immunotherapy treatments.
Not a fit: Dogs with other types of cancer or those not diagnosed with osteosarcoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapies for dogs with osteosarcoma, improving their chances of recovery.
How similar studies have performed: Previous research has shown promise in using dendritic cell hyperactivation in other cancer models, suggesting potential for success in this approach.
Where this research is happening
Boston, United States
- Tufts University Boston — Boston, United States (Active)
Researchers
- Principal investigator: London, Cheryl a — Tufts University Boston
- Study coordinator: London, Cheryl a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.